Immunization & Vaccination News
Immunizations and Vaccines Articles
CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population
Today, the FDA issued an emergency use authorization for the first oral antiviral for treatment of COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds).
National Influenza Vaccination Week Observed December 5-11, 2021
The South Dakota Department of Health is recognizing National Influenza Vaccination Week by inviting all South Dakotans (6 months or older) to get their annual flu vaccine before the week’s end.
COVID-19 Vaccine Now Available for Children Ages 5-11 - Parental Authorization is Required
PIERRE, S.D. – Today, following approval of the Pfizer-BioNTech® COVID-19 Vaccine for children ages 5-11 by the U.S. Food and Drug Administration (FDA), and the final recommendation from the Centers for Disease Control and Prevention (CDC), the South Dakota Department of Health released the following statement:
Pfizer Booster Shots Authorized to Increase Protection Against COVID-19
Pierre, S.D. – Today, the Centers for Disease Control and Prevention (CDC) released its recommendations, authorizing the use of Pfizer-BioNTech® third booster doses for certain populations, to include high-risk workers and residents in institutional settings.
Department of Health Releases Form for COVID-19 Vaccination Event(s) Assistance
Pierre, S.D. – Today, the South Dakota Department of Health (SD-DOH) released an online assistance form for K-12 schools, colleges & universities, congregate living centers, businesses and community/faith based organizations to request help in hosting a COVID-19 vaccination event, in partnership with a local vaccine provider.
Pfizer and Moderna COVID-19 Vaccines for Immunocompromised Individuals Now Available
PIERRE, S.D. – Today, the South Dakota Department of Health announced that a third shot of both Pfizer and Moderna COVID-19 vaccines are available for immunocompromised individuals following approval by the U.S. Centers for Disease Control and Prevention (CDC), of the U.S. Food and Drug Administration (FDA) emergency use authorization amendment.